Search results: Sage Journals

Free accessResearch articleFirst published October, 2004

Prevalance of Heparin-Dependent Platelet-Activating Antibodies in Preterm Newborns After Exposure to Unfractionated Heparin

Praveen Kumar, Debra A. Hoppensteadt, M. Margaret Prechel [...]

Clinical and Applied Thrombosis/Hemostasis

Free accessResearch articleFirst published January, 2013

Murine Monoclonal Antibody to Platelet Factor 4/Heparin Complexes as a Potential Reference Standard for Platelet Activation Assays in Heparin-Induced Thrombocytopenia

Reiko Asada, Keiko Wanaka, Jeanine Walenga [...]

Clinical and Applied Thrombosis/Hemostasis

Free accessResearch articleFirst published October, 2014

Monitoring of Unfractionated Heparin Using Activated Partial Thromboplastin Time

Je Sang Kim, Hyun Jong Lee, Ji Dong Sung [...]

Clinical and Applied Thrombosis/Hemostasis

Open accessResearch articleFirst published 2022

Patients’ Plasma Activity of Heparin,low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips

Job Harenberg, Svetlana Hetjens, Christel Weiss

Clinical and Applied Thrombosis/Hemostasis

Restricted accessOtherFirst published May, 2011

Osteogenic activities of MC3T3-E1 cells on heparin-immobilized poly(caprolactone) membranes

Menemşe Gümüşderelioğlu, Ayşe Karakeçili, T Tolga Demirtaş

Journal of Bioactive and Compatible Polymers

Restricted accessResearch articleFirst published December, 1997

Activation of the Clotting System: Heparin-Coated versus Non Coated Systems for Extracorporeal Circulation

B. Urlesberger, G. Zobel, S. Rödl [...]

The International Journal of Artificial Organs

Restricted accessResearch articleFirst published September, 1983

Adjusting Heparin Infusion Rates from the Initial Response to Activated Coagulation Time

Paul G. Hattersley, J. Chris Mitsuoka, Robert J. Ignoffo [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published October, 2025

Factors associated with activated clotting time following heparin administration in pediatric cardiopulmonary bypass: A retrospective study

Mizuho Hida, Koichi Kashiwa, Hideo Kurosawa [...]

Perfusion

Restricted accessResearch articleFirst published September, 2014

Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients

S Atallah, M Liebl, K Fitousis [...]

Perfusion

Restricted accessResearch articleFirst published March, 2009

The relationship between heparin level and activated clotting time in the adult cardiac surgery population

DJ FitzGerald, A Patel, SC Body [...]

Perfusion

Free accessResearch articleFirst published October, 2004

Prevalance of Heparin-Dependent Platelet-Activating Antibodies in Preterm Newborns After Exposure to Unfractionated Heparin

Praveen Kumar, Debra A. Hoppensteadt, M. Margaret Prechel [...]

Clinical and Applied Thrombosis/Hemostasis

Free accessResearch articleFirst published January, 2013

Murine Monoclonal Antibody to Platelet Factor 4/Heparin Complexes as a Potential Reference Standard for Platelet Activation Assays in Heparin-Induced Thrombocytopenia

Reiko Asada, Keiko Wanaka, Jeanine Walenga [...]

Clinical and Applied Thrombosis/Hemostasis

Free accessResearch articleFirst published October, 2014

Monitoring of Unfractionated Heparin Using Activated Partial Thromboplastin Time

Je Sang Kim, Hyun Jong Lee, Ji Dong Sung [...]

Clinical and Applied Thrombosis/Hemostasis

Open accessResearch articleFirst published 2022

Patients’ Plasma Activity of Heparin,low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips

Job Harenberg, Svetlana Hetjens, Christel Weiss

Clinical and Applied Thrombosis/Hemostasis

Restricted accessOtherFirst published May, 2011

Osteogenic activities of MC3T3-E1 cells on heparin-immobilized poly(caprolactone) membranes

Menemşe Gümüşderelioğlu, Ayşe Karakeçili, T Tolga Demirtaş

Journal of Bioactive and Compatible Polymers

Restricted accessResearch articleFirst published December, 1997

Activation of the Clotting System: Heparin-Coated versus Non Coated Systems for Extracorporeal Circulation

B. Urlesberger, G. Zobel, S. Rödl [...]

The International Journal of Artificial Organs

Restricted accessResearch articleFirst published September, 1983

Adjusting Heparin Infusion Rates from the Initial Response to Activated Coagulation Time

Paul G. Hattersley, J. Chris Mitsuoka, Robert J. Ignoffo [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published October, 2025

Factors associated with activated clotting time following heparin administration in pediatric cardiopulmonary bypass: A retrospective study

Mizuho Hida, Koichi Kashiwa, Hideo Kurosawa [...]

Perfusion

Restricted accessResearch articleFirst published September, 2014

Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients

S Atallah, M Liebl, K Fitousis [...]

Perfusion

Restricted accessResearch articleFirst published March, 2009

The relationship between heparin level and activated clotting time in the adult cardiac surgery population

DJ FitzGerald, A Patel, SC Body [...]

Perfusion